Skip to main content
Premium Trial:

Request an Annual Quote

Predictive Diagnostics Closes Doors as Nasdaq Delists LSBC

NEW YORK, Jan. 3 (GenomeWeb News) - Faced with delisting from the Nasdaq exchange, Large Scale Biology has shuttered its operations, including its proteomics subsidiary, Predictive Diagnostics, GenomeWeb News has learned.


LSBC disclosed its plan in a filing with the Securities Exchange Commission. Though the filing did not mention Predictive Diagnostics' fate, when GenomeWeb News called the company for details today a recorded message said, "Effective December 23, 2005, Predictive Diagnostics, Inc. has ceased operations. Calls to this number will not be returned."


GenomeWeb News has reported LSBC's financial woes in the past. After its stock price plummeted to less than $1 per share in June, Nasdaq threatened to delist the company unless the share price went back up in 180 days.


According to the SEC filing, LSBC's stock ceased trading at the end of trading on Dec. 23.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.